Was on CNBC this morning.Did anyone hear what he said?Because I think I heard him being most excited about a combination treatment for Colon Cancer?And since the following is true:Fortunately, it appears Cotellic is working well in colon cancer patients, too. In combination with Roche's Tecentriq, the drugs produced an objective response rate of 17% of the 23 patients in the phase 1b trial, with four confirmed partial responses and five patients with stable disease. Not bad for patients with few options remaining.I wonder if he was thinking about Cotellic?
Right when he said,"Tecentriq combined with one of our targeted agents in colorectal cancer," all I could think was it's possibly an Exelixis combo..
Key Statistics under the Company column on the left side of the Yahoo quote page;shows "Shares Short (prior month) 46.94M."